Sort by
Refine Your Search
-
Listed
-
Category
-
Country
- United States
- United Kingdom
- Germany
- France
- Sweden
- Portugal
- Spain
- Poland
- Belgium
- Denmark
- Canada
- Norway
- Netherlands
- Czech
- Singapore
- Italy
- Hong Kong
- Switzerland
- Austria
- Ireland
- Romania
- Australia
- Finland
- Japan
- China
- Croatia
- Luxembourg
- Brazil
- Greece
- Bulgaria
- India
- Mexico
- Macau
- Morocco
- Latvia
- Lithuania
- New Zealand
- United Arab Emirates
- Worldwide
- Andorra
- Hungary
- Malta
- Saudi Arabia
- Slovakia
- South Africa
- South Korea
- Taiwan
- 37 more »
- « less
-
Program
-
Field
- Medical Sciences
- Biology
- Economics
- Computer Science
- Business
- Science
- Engineering
- Chemistry
- Mathematics
- Materials Science
- Law
- Education
- Psychology
- Arts and Literature
- Humanities
- Environment
- Sports and Recreation
- Physics
- Electrical Engineering
- Social Sciences
- Philosophy
- Linguistics
- Earth Sciences
- Design
- 14 more »
- « less
-
systemic AML therapies. Antibody-based therapeutics, including drug-conjugates (ADCs) and bispecific T-cell engagers (BiTEs) have emerged as new effective targeted therapies for a range of cancer types. In a
-
available from July 2026. The research group studies functional immunogenetics and adaptive immunity - particularly in relation to autoimmune diseases (https://www.med.uio.no/klinmed/english/people/aca
-
inflammatory systems; applying cutting-edge multi-omics technologies such as single-cell sequencing and spatial transcriptomics to translational research; and developing novel therapeutic strategies and
-
Number: 150844754 The Hematopoietic (Stem) Cell Transplant Program at Dana-Farber/Boston Children's Cancer and Blood Disorders Center is one of the largest and most experienced pediatric stem cell
-
elucidation of membrane protein complexes and integrates fundamental cell biology and structural biology by cryo- electron microscopy. The lab has a strong track record in investigating scramblases and their
-
translational breast cancer research. We use cell culture and animal models to examine molecular mechanisms regulating the development and progression of breast cancer with a specific focus on the tumor
-
. This researcher will broadly support research at the intersection of cell, molecular, and developmental biology using quantitative imaging tools. RESPONSIBILITIES: 50%: Maintain, operate, and provide training
-
include work on patient material, cell lines and primary cells. The work may also contain handling of animals and studies in animal model systems. Methods used in the studies include biochemical methods, as
-
toxicity predictions. Must have familiarity with data generated by cell screening assays, cell painting, and cheminformatics. Must have experience in research software development, FAIR data/open science
-
The University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | 2 days ago
peer-reviewed publications. Education and Experience: The candidate should have previous experience working with lab animal models, cell culture, molecular biology and immunology techniques. Motivation